Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Potential and real 'antineoplastic' and metabolic effect of metformin in diabetic and nondiabetic postmenopausal females.

Future oncology (London, England) - 1 Jan 2015

Berstein Lev M, Vasilyev Dmitry A, Iyevleva Aglaya G, Boyarkina Marina P, Poroshina Tatyana E, Khadzhimba Angela S, Imyanitov Evgeny N

Abstract excerpt

AIM: The goal of this study was to determine if the single nucleotide polymorphisms marking potential sensitivity to metformin (MF) correlate with hormone-metabolic status as well as with actual response to MF in postmenopausal cancer patients with or without Type 2 diabetes mellitus and in diabetics without cancer. PATIENTS & METHODS: The carriage of ten different SNPs was evaluated in all patients by PCR, and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimetabolites, Antineoplastic
Share to Diabetes Mellitus, Type 2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hormones

Share to Hypoglycemic Agents

Share to Metformin

Share to Neoplasms

Share to Pharmacogenetics

Share to Postmenopause

Source

Identifiers

PMID: 25757680
DOI: 10.2217/fon.14.317

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Potential and real 'antineoplastic' and metabolic effect of metformin in diabetic and nondiabetic postmenopausal females.PMID 25757680Read ↗

Genetic polymorphisms potentially associated with response to metformin in postmenopausal diabetics suffering and not suffering with cancer.Semantic proximity Read ↗

[Genetic testing of constitutive sensitivity to metformin in cancer patients with and without diabetes].Semantic proximity Read ↗

An Update on the Pharmacogenomics of Metformin: Progress, Problems and PotentialSemantic proximity Read ↗

[Metformin - new data for an "old", but efficient, safe and reliable antidiabetic drug].Semantic proximity Read ↗

Anti-tumor activity of metformin: from metabolic and epigenetic perspectivesSemantic proximity Read ↗

The pharmacogenetics of metformin.Semantic proximity Read ↗

Evaluation of the suitability of 19 pharmacogenomics biomarkers for individualized metformin therapy for type 2 diabetes patients.Semantic proximity Read ↗

Effects of Metformin on Transcriptomic and Metabolomic Profiles in Breast Cancer Survivors Enrolled in the Randomized Placebo-Controlled MetBreCS TrialSemantic proximity Read ↗

New evidence: Metformin unsuitable as routine adjuvant for breast cancer: a drug-target mendelian randomization analysis.Semantic proximity Read ↗

Epigenetic markers associated with metformin response and intolerance in drug-naïve patients with type 2 diabetesSemantic proximity Read ↗

The Pharmacogenetics of Metformin in Women with Polycystic Ovary Syndrome: A Randomized TrialSemantic proximity Read ↗

Effects of metformin on lymphocyte DNA damage in obese individuals among Kazakh populationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.